ARCHIVES

Remaining DCT Recompetitions

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

Advisors say NCI needs to reach out to other fields.

July 15, 2005

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975